Melanie Kappelmann-Fenzl

Professor

Deggendorf Institute of Technology

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Tissue Engineering Tissue Engineering professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Melanie Kappelmann-Fenzl is a faculty member at the Deggendorf Institute of Technology in Germany. Her research focuses on melanoma, specifically in areas such as molecular analysis of dormancy, regulation of cell survival, and the effects of various genetic factors on tumor progression. Recent publications highlight her work on bioprinting models, splicing control mechanisms, and the impact of chromatin structure on melanoma cells.

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (7)

Aldo Leal‐Egaña

GERMANY

View details

Felix Beyer

GERMANY

View details

Stefan Fischer

Deggendorf Institute of Technology

GERMANY

View details

Paolo Ceppi

DENMARK

View details

Isabel Stüfchen

Ludwig Maximilian University of Munich

GERMANY

View details

Anselm Horn

Friedrich-Alexander Universität Erlangen-Nürnberg

GERMANY

View details

Gunter Meister

University of Regensburg

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Melanie Kappelmann-Fenzl

Research Interests

Explore related searches

Contact this professor

About

Articles (14)

Modeling a mesenchymal cell state by bioprinting for the molecular analysis of dormancy in melanoma

Featured Cover

Splicing control by PHF5A is crucial for melanoma cell survival

Loss of miR-101-3p in melanoma stabilizes genomic integrity, leading to cell death prevention

Alternative Wnt-signaling axis leads to a break of oncogene-induced senescence

Transcription factor activating enhancer-binding protein 2ε (AP2ε) modulates phenotypic plasticity and progression of malignant melanoma.

A previously unknown Argonaute 2 variant positively modulates the viability of melanoma cells

Two novel CreERT2 transgenic mouse lines to study melanocytic cells in vivo

Knockdown of Lamin B1 and the Corresponding Lamin B Receptor Leads to Changes in Heterochromatin State and Senescence Induction in Malignant Melanoma

HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma

Impact of <i>CYLD</i> on chromatin structure and histone methylation in malignant melanoma.

Loss of Gene Information: Discrepancies between RNA Sequencing, cDNA Microarray, and qRT-PCR

Molecular Changes Induced in Melanoma by Cell Culturing in 3D Alginate Hydrogels

3D Spheroids Versus 3D Tumor-Like Microcapsules: Confinement and Mechanical Stress May Lead to the Expression of Malignant Responses in Cancer Cells.

Collaborators (7)

Aldo Leal‐Egaña

Felix Beyer

Stefan Fischer

Paolo Ceppi

Isabel Stüfchen

Anselm Horn

Gunter Meister

Make your next move.